GB2010090A - Compositions useful against Parkinson's disease - Google Patents
Compositions useful against Parkinson's diseaseInfo
- Publication number
- GB2010090A GB2010090A GB7848846A GB7848846A GB2010090A GB 2010090 A GB2010090 A GB 2010090A GB 7848846 A GB7848846 A GB 7848846A GB 7848846 A GB7848846 A GB 7848846A GB 2010090 A GB2010090 A GB 2010090A
- Authority
- GB
- United Kingdom
- Prior art keywords
- disease
- compositions useful
- useful against
- against parkinson
- parkinsonian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86240377A | 1977-12-20 | 1977-12-20 | |
US87313178A | 1978-01-30 | 1978-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB2010090A true GB2010090A (en) | 1979-06-27 |
Family
ID=27127691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7848846A Withdrawn GB2010090A (en) | 1977-12-20 | 1978-12-18 | Compositions useful against Parkinson's disease |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS54122733A (it) |
AU (1) | AU4271878A (it) |
DE (1) | DE2853409A1 (it) |
FR (1) | FR2412311A1 (it) |
GB (1) | GB2010090A (it) |
IL (1) | IL56238A0 (it) |
IT (1) | IT7852286A0 (it) |
NL (1) | NL7812207A (it) |
ZA (1) | ZA787152B (it) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2307011A4 (en) * | 2008-06-20 | 2011-08-24 | Afecta Pharmaceuticals Inc | USE OF ISOINDOLENE FOR THE TREATMENT OF NEURO BEHAVIORAL DISORDERS |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816445A (en) * | 1984-06-21 | 1989-03-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Crystalline alpha-maltose |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7117207A (it) * | 1970-12-24 | 1972-06-27 | ||
FI370674A (it) * | 1974-01-02 | 1975-07-03 | Sandoz Ag | |
PH15001A (en) * | 1977-07-25 | 1982-03-22 | Sandoz Ag | Prolactin secretion inhibitors |
-
1978
- 1978-12-11 DE DE19782853409 patent/DE2853409A1/de not_active Withdrawn
- 1978-12-14 IT IT7852286A patent/IT7852286A0/it unknown
- 1978-12-15 NL NL7812207A patent/NL7812207A/xx not_active Application Discontinuation
- 1978-12-18 IL IL56238A patent/IL56238A0/xx unknown
- 1978-12-18 GB GB7848846A patent/GB2010090A/en not_active Withdrawn
- 1978-12-19 AU AU42718/78A patent/AU4271878A/en active Pending
- 1978-12-20 ZA ZA787152A patent/ZA787152B/xx unknown
- 1978-12-20 JP JP15651878A patent/JPS54122733A/ja active Pending
- 1978-12-20 FR FR7835783A patent/FR2412311A1/fr not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2307011A4 (en) * | 2008-06-20 | 2011-08-24 | Afecta Pharmaceuticals Inc | USE OF ISOINDOLENE FOR THE TREATMENT OF NEURO BEHAVIORAL DISORDERS |
EP3156053A1 (en) * | 2008-06-20 | 2017-04-19 | Afecta Pharmaceuticals, Inc. | Use of isoindoles for the treatment of neurobehavioral disorders |
Also Published As
Publication number | Publication date |
---|---|
ZA787152B (en) | 1980-08-27 |
IT7852286A0 (it) | 1978-12-14 |
AU4271878A (en) | 1979-06-28 |
NL7812207A (nl) | 1979-06-22 |
IL56238A0 (en) | 1979-03-12 |
FR2412311A1 (fr) | 1979-07-20 |
JPS54122733A (en) | 1979-09-22 |
DE2853409A1 (de) | 1979-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1774276A (en) | Counterforce brace fora wrist or forearm | |
ES8202543A1 (es) | Procedimiento para la preparacion de sulfonilureas | |
AU564648B2 (en) | Insulin agent | |
LV5483A3 (lv) | Izohinolinija atvasinajumu iegusanas panemiens | |
ES8504678A1 (es) | Procedimiento para la preparacion de un derivado de insulina | |
NO933615D0 (no) | Tiazolidindionderivater, fremstilling og anvendelse derav | |
ES2066461T3 (es) | Nuevos derivados fosfolipidicos de nucleosidos, su preparacion, asi como su utilizacion como medicamentos antiviricos. | |
ES466281A1 (es) | Procedimiento para preparar derivados de ciclopropano. | |
EP0444196A4 (en) | Agent for treatment and prophylaxis of ischemic disease of heart or brain | |
NZ185169A (en) | 2,3-dihydroimidazo(2, 1-b) thiazole derivatives: process and pharmaceutical compositions | |
ES545330A0 (es) | Un procedimiento para preparar derivados de 1,3-difosfonato | |
ES462103A1 (es) | Procedimiento para la preparacion del derivado yodurado de cloruro de benzalconio. | |
GB2010090A (en) | Compositions useful against Parkinson's disease | |
SE7811455L (sv) | 2-imino-imidazolidin-derivat | |
IE880248L (en) | 5-(3-Alkyl-5-tert¹butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiazines, a¹process for the preparation thereof, medicaments containing¹same, and the use thereof | |
ES471672A1 (es) | Un procedimiento para la preparacion de un peptido | |
ES475346A1 (es) | Un procedimiento para la preparacion de cloruros de acido butirico halogenados | |
ES471874A1 (es) | Procedimiento para la preparacion de nuevos derivados de 1.2.4-triazin-5-ona | |
FI890173A (fi) | Isoxazoler med nootropisk verkan. | |
ES468293A1 (es) | Procedimiento para preparar derivados de a-nor-androsta-3 (5),16-dien-2-ona. | |
NL7811355A (nl) | Werkwijze voor de dehydrochlorering van 1,1,2-trichloorethaan. | |
GB2000784A (en) | Analgestic Polypeptides | |
JPS549237A (en) | (2s, 3r)-3-amino-2-hydroxy-4-p-hydroxyphenylbutanoyl-(s)-leucine and its preparation | |
IT1245390B (it) | Composizione farmaceutica ad attivita' antivirale | |
ES469426A1 (es) | Un procedimiento para la preparacion de derivados n-al- quil-n-iminometilicos de tienamicina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |